TUESDAY, Dec. 2, 2025 (HealthDay News) -- Long-term glucagon-like peptide-1 (GLP-1) therapies combined with intensive behavioral therapy are recommended for adu
WHO: Long-Term GLP-1 Therapies Recommended for Adults With Obesity
HealthDayJust now
63
HealthDayJust now
TUESDAY, Dec. 2, 2025 (HealthDay News) -- Long-term glucagon-like peptide-1 (GLP-1) therapies combined with intensive behavioral therapy are recommended for adu